Skin Cancer

For some patients, doctors recommend treatment after surgery to reduce the risk of melanoma developing again.

The cancer experience is different for all of us that is sometimes easy to navigate and sometimes not at all. Yet we all join the same team once we hear the words “you have cancer.” We can help each other to cope.

When talking or reading about cancer these days, immunotherapy seems to be the magic word.

Amid all the excitement over recently approved immunotherapies and targeted drugs for the treatment of later-stage melanoma is an important emerging message: In many cases, two is better than one.

Melanoma has been a primary focus in immunotherapy research because of intriguing evidence that some people's immune systems are better able to keep the cancer in check.

What should be done to protect children from the sun's harmful rays? The same multi-pronged approach that experts recommend for adults.

Surviving melanoma can mean lifelong skin checks, scars and, in some cases, long-term medical treatment.

December 10 was my New Year's Eve — it was full of hope and renewal.

Recent FDA approvals have added to the growing number of treatment options for patients with advanced melanoma.

After a cancer diagnosis, patients and their caregivers must decide how much information to share with loved ones, and who should manage the communication plan.

Using sunscreen and protective clothing are good preventive measures.

By learning how to identify melanoma, patients can seek early diagnoses, potentially minimizing their treatment needs.

The FDA has expanded the approval for single-agent Keytruda to include the frontline treatment of patients with advanced melanoma regardless of BRAF status and to include the treatment of patients with Yervoy-refractory melanoma.

My letter to Ty, a young man taken before his time.

Former U.S. president Jimmy Carter once again provided an update on his health today.

I feel terror and beauty all around me, but it's OK to feel them both — they've gotten me this far.

Many patients who have had melanoma do not conduct regular skin self-examinations, and those who do check themselves do not use sufficient tools or techniques.

The approval was based on a substantial improvement in overall survival (OS) in a phase 3 study.

The approval was based on an extension in overall survival from two phase 3 studies.

Adding the MEK inhibitor Mekinist to the BRAF inhibitor Tafinlar significantly improves long-term outcomes while lowering certain adverse events associated with either agent alone.

Two-time cancer survivor discusses her fatigue and possible answers for it.

To gain insight into the recent flurry of FDA approvals in melanoma, CURE spoke with Tim Turnham, the executive director of the Melanoma Research Foundation.

It's exhausting trying to keep everybody positive about my progress.

The approval was based on an extension in progression-free survival in the phase 3 coBRIM study.

The approval is based on results from the phase 3 EORTC 18071 trial, in which adjuvant Yervoy reduced the risk of recurrence by 25 percent versus placebo.